Study of the Impact of the Minimum Inhibitory Concentration and Susceptible Cut-off Points (CLSI, EUCAST, and Pharmacokinetics/Pharmacodynamics)in Prognosis of Bacteremia by Enterobacteriaceae
Clinical trial NCT02005159 · COMPLETED
Trial details
- NCT number
- NCT02005159
- Sponsor
- Fundación Pública Andaluza Progreso y Salud
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-03-01
- Primary completion
- 2014-12-01
- Enrollment
- 1064
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.